Multiple-dose pharmacokinetics of fluoxetine in healthy Mexican subjects
Carrasco-Portugal, M.C.; Granados-Soto, V.; Reyes-García, G.; Medina-Santillán, R.; Herrera, J.E.; Flores-Murrieta, F.J.
Proceedings of the Western Pharmacology Society 44: 69-70
2001
ISSN/ISBN: 0083-8969 PMID: 11793998 Document Number: 534846
Document emailed within 1 workday
Related Documents
Wiedemann, I.; Peil, H.; Justus, H.; Adamus, S.; Brantl, V.; Lohmann, H. 1985: Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers Arzneimittel-Forschung 35(6): 964-969Sakashita, M.; Yamaguchi, T.; Miyazaki, H.; Sekine, Y.; Nomiyama, T.; Tanaka, S.; Miwa, T.; Harasawa, S. 1993: Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects Arzneimittel-Forschung 43(8): 867-872
Smith, R.B.; Gwilt, P.R.; Wright, C.E. 1983: Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men Clinical Pharmacy 2(2): 139-143
Fleishaker, J.C.; Hulst, L.K.; Peters, G.R. 1994: Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 32(5): 223-230
Pérez-Guillé, G.; Guillé-Pérez, A.án.; Toledo-López, A.; Juárez-Olguín, H.; Flores Pérez, C.; Flores-Pŕez, J.; Carrasco-Portugal, M.; Lares-Asseff, I.; Camacho-Vieyra, A.él. 2005: Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers Proceedings of the Western Pharmacology Society 48: 84-88
Aguilar-Cota, M.E.; Flores-Murrieta, F.J.; Menéndez, J.C.; Hong, E.; Castañeda-Hernández, G. 1992: Renal and metabolic clearances of sulfamethoxazole in Mexican healthy subjects Proceedings of the Western Pharmacology Society 35: 103-106
Tateishi, T.; Kobayashi, S.; Shigeyama, C.; Nakamura, T.; Kobayashi, H. 1998: Pharmacokinetics of KW-4679 in the elderly: single-dose and multiple-dose trials Drugs under Experimental and Clinical Research 24(1): 1-7
Breuel, H.P.; Müller-Oerlinghausen, B.; Nickelsen, T.; Heine, P.R. 1995: Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 33(7): 415-419
Wittayalertpanya, S.; Chompootaweep, S.; Thaworn, N. 2006: The pharmacokinetics of pioglitazone in Thai healthy subjects Journal of the Medical Association of Thailand 89(12): 2116-2122
Macgregor, D.A.; Smith, T.E.; Prielipp, R.C.; Butterworth, J.F.; James, R.L.; Scuderi, P.E. 2000: Pharmacokinetics of dopamine in healthy male subjects Anesthesiology 92(2): 338-346
Sudo, R.T.; Melo, P.A.; Suarez-Kurtz, G. 1990: Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects Brazilian Journal of Medical and Biological Research 23(12): 1315-1321
Wei, X.; Ding, L.; Gao, J-min.; Li, J.; Zhang, S-qiang.; Shen, J-ping.; Zhang, Y-di. 2004: Pharmacokinetics and bioequivalence of eperisone hydrochloride tablet in healthy subjects Yao Xue Xue Bao 39(4): 309-311
Jiang, H.; Ding, L.; Yang, J.; Huang, X.; Liu, G-yu.; Zhang, Z-xing. 2004: Pharmacokinetics and bioequivalence of trimebutine dispersive tablet in healthy subjects Yao Xue Xue Bao 39(3): 208-211
Lal, J.; Asthana, O.P.; Nityanand, S.; Gupta, R.C. 1995: Pharmacokinetics of centchroman in healthy female subjects after oral administration Contraception 52(5): 297-300
Flor, S.; Guay, D.; Opsahl, J.; Tack, K.; Matzke, G. 1991: Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment International Journal of Clinical Pharmacology Research 11(3): 115-121
Witte, P.U.; Irmisch, R.; Hajdú, P. 1985: Pharmacokinetics of pheniramine (Avil) and metabolites in healthy subjects after oral and intravenous administration International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 59-62
Loniewski, I.; Sawrymowicz, M.; Pawlik, A.; Wójcicki, J.; Drozdzik, M. 2001: Lack of effect of physical exercise on pharmacokinetics of acetaminophen tablets in healthy subjects Acta Poloniae Pharmaceutica 58(2): 141-144
Yamaguchi, T.; Hashizume, T.; Matsuda, M.; Sakashita, M.; Fujii, T.; Sekine, Y.; Nakashima, M.; Uematsu, T. 1994: Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects Arzneimittel-Forschung 44(1): 59-64
Hilli, J.; Korhonen, T.; Turpeinen, M.; Hokkanen, J.; Mattila, S.; Laine, K. 2008: The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism Journal of Clinical Pharmacology 48(8): 986-994
Paczkowski, D.; Sadowski, Z.; Filipek, M.; Koliński, P. 1990: Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects Polish Journal of Pharmacology and Pharmacy 42(4): 365-375